Rare but potentially permanent darkening of the iris (brown pigment).

The FDA classifies Latisse as a drug, not a cosmetic, because its active ingredient () physically alters the hair growth cycle. Medical supervision is required to monitor for potential side effects, including:

Reversible darkening of the eyelid skin where the solution is applied.